PE20041026A1 - Composicion que comprende un inhibidor de ciclooxigenasa-2 selectivo soluble en agua - Google Patents
Composicion que comprende un inhibidor de ciclooxigenasa-2 selectivo soluble en aguaInfo
- Publication number
- PE20041026A1 PE20041026A1 PE2003001182A PE2003001182A PE20041026A1 PE 20041026 A1 PE20041026 A1 PE 20041026A1 PE 2003001182 A PE2003001182 A PE 2003001182A PE 2003001182 A PE2003001182 A PE 2003001182A PE 20041026 A1 PE20041026 A1 PE 20041026A1
- Authority
- PE
- Peru
- Prior art keywords
- skin
- water
- inhibitor
- composition including
- drugs
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
- A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
- A61K9/703—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms characterised by shape or structure; Details concerning release liner or backing; Refillable patches; User-activated patches
- A61K9/7038—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer
- A61K9/7046—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds
- A61K9/7053—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds obtained by reactions only involving carbon to carbon unsaturated bonds, e.g. polyvinyl, polyisobutylene, polystyrene
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/415—1,2-Diazoles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/42—Oxazoles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
- A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
- A61K9/703—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms characterised by shape or structure; Details concerning release liner or backing; Refillable patches; User-activated patches
- A61K9/7038—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer
- A61K9/7046—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds
- A61K9/7053—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds obtained by reactions only involving carbon to carbon unsaturated bonds, e.g. polyvinyl, polyisobutylene, polystyrene
- A61K9/7061—Polyacrylates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
- A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
- A61K9/703—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms characterised by shape or structure; Details concerning release liner or backing; Refillable patches; User-activated patches
- A61K9/7038—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer
- A61K9/7046—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds
- A61K9/7069—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds obtained otherwise than by reactions only involving carbon to carbon unsaturated bonds, e.g. polysiloxane, polyesters, polyurethane, polyethylene oxide
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Landscapes
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Medicinal Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Epidemiology (AREA)
- Dermatology (AREA)
- General Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Pain & Pain Management (AREA)
- Rheumatology (AREA)
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Abstract
PARA SER APLICADO A UN AREA DE LA PIEL EN EL TRATAMIENTO LOCAL Y/O SISTEMICO DE UN TRANSTORNO MEDIADO POR COX-2, Y QUE COMPRENDE: 1)UNA LAMINA DE SOPORTE QUE PUEDE CONFORMARSE DE FORMA FLEXIBLE AL AREA DE LA PIEL, TENIENDO LA MISMA SUPERFICIES ENFRENTADAS QUE ESTAN RESPECTIVAMENTE DISTAL Y PROXIMAL A LA PIEL CUANDO SE APLICA; Y, 2)UN RECUBRIMIENTO SOBRE LA SUPERFICIE PROXIMAL DE (1), QUE A SU VEZ COMPRENDE: a)UN ADHESIVO; b)UN AGENTE ACTIVO SOLUBLE EN AGUA SELECCIONADO DE: FARMACOS O PROFARMACOS, O SUS SALES INHIBIDORES DE COX-2 SELECTIVOS, EL CUAL ESTA EN UNA CANTIDAD TOTAL TERAPEUTICAMENTE EFECTIVA Y DISPERSO EN UNA MATRIZ QUE COMPRENDE DE CERO A MENOS DE UNA CANTIDAD EFECTIVA PARA SOLUBILIZAR EL AGENTE ACTIVO EN TOTAL DE UNO O MAS DISOLVENTES DISTINTOS DEL ADHESIVO
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US42820102P | 2002-11-21 | 2002-11-21 |
Publications (1)
Publication Number | Publication Date |
---|---|
PE20041026A1 true PE20041026A1 (es) | 2005-02-05 |
Family
ID=32393362
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PE2003001182A PE20041026A1 (es) | 2002-11-21 | 2003-11-21 | Composicion que comprende un inhibidor de ciclooxigenasa-2 selectivo soluble en agua |
Country Status (15)
Country | Link |
---|---|
US (1) | US20040126415A1 (es) |
EP (1) | EP1572166A1 (es) |
JP (1) | JP2006509759A (es) |
AR (1) | AR042102A1 (es) |
AU (1) | AU2003291386A1 (es) |
BR (1) | BR0316463A (es) |
CA (1) | CA2506628A1 (es) |
GT (1) | GT200300249A (es) |
MX (1) | MXPA05004989A (es) |
NL (1) | NL1024830C2 (es) |
PA (1) | PA8589001A1 (es) |
PE (1) | PE20041026A1 (es) |
TW (1) | TW200503787A (es) |
UY (1) | UY28086A1 (es) |
WO (1) | WO2004047814A1 (es) |
Families Citing this family (13)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EA012599B1 (ru) | 2003-04-10 | 2009-10-30 | Ньюроджескс, Инк. | Способы и композиции для введения агонистов trpv1 |
US7666914B2 (en) * | 2004-06-03 | 2010-02-23 | Richlin David M | Topical preparation and method for transdermal delivery and localization of therapeutic agents |
KR20070121666A (ko) * | 2005-02-14 | 2007-12-27 | 노이로제스엑스, 인코포레이티드 | Trpv1 작용제의 전달용 장치 |
WO2006105481A1 (en) * | 2005-03-30 | 2006-10-05 | Neurogesx, Inc. | Low-concentration capsaicin patch and methods for treating neuropathic pain |
DE102005050431A1 (de) * | 2005-10-21 | 2007-04-26 | Lts Lohmann Therapie-Systeme Ag | Transdermales therapeutisches System zur Verabreicherung lipophiler und/oder wenig hautpermeabler Wirkstoffe |
US20090081281A1 (en) * | 2006-05-10 | 2009-03-26 | Gerard Farmer | Photosensitizer Formulation for Topical Applications |
DE102006054732B4 (de) * | 2006-11-21 | 2010-12-30 | Lts Lohmann Therapie-Systeme Ag | Transdermales therapeutisches System mit Ionenpaar-Mikroreservoiren |
JP4327841B2 (ja) * | 2006-12-20 | 2009-09-09 | 日東電工株式会社 | 経皮吸収製剤の製造装置および製造方法 |
EP2278947A4 (en) * | 2008-05-21 | 2013-11-06 | Teikoku Pharma Usa Inc | TREATMENT OF DYSMENORRHEA BY TRANSDERMAL ADMINISTRATION OF NON-STEROIDAL ANTI-INFLAMMATORY DRUGS |
JP2012020991A (ja) * | 2010-06-16 | 2012-02-02 | Takasago Internatl Corp | 経皮吸収促進剤、及びこれを含有する皮膚外用製剤 |
US9814911B2 (en) * | 2011-07-15 | 2017-11-14 | Robert Benson Aylor | Skin and hair treatments |
US20180271813A1 (en) * | 2014-11-10 | 2018-09-27 | Achelios Therapeutics, Inc. | Sprayable analgesic compositions |
KR102042456B1 (ko) * | 2018-03-22 | 2019-11-08 | 크리스탈지노믹스(주) | 경피흡수제제 |
Family Cites Families (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
ES2311571T3 (es) * | 1996-04-12 | 2009-02-16 | G.D. Searle Llc | Derivados de bencenosulfonamida sustituidos como profarmacos de inhibidores de cox-2. |
CN1231592A (zh) * | 1996-10-30 | 1999-10-13 | 瑟垃技术有限公司 | 作为渗透促进剂的羟乙酸及其盐的脂肪酸酯 |
AU2816700A (en) * | 1999-03-01 | 2000-09-21 | Amarin Technologies S.A. | Transdermal device comprising non-steroidal anti-inflammatory drugs incorporatedin acrylic adhesive polymer matrix |
US6309663B1 (en) * | 1999-08-17 | 2001-10-30 | Lipocine Inc. | Triglyceride-free compositions and methods for enhanced absorption of hydrophilic therapeutic agents |
IN191512B (es) * | 2000-01-21 | 2003-12-06 | Panacea Biotech | |
DE10032132A1 (de) * | 2000-07-01 | 2002-01-17 | Lohmann Therapie Syst Lts | Dermales Therapeutisches System enthaltend nichtsteroidale Antiphlogistika mit selektiver COX-2-Hemmung |
AU2002306868A1 (en) * | 2001-03-28 | 2002-10-15 | Pharmacia Corporation | Therapeutic combinations for cardiovascular and inflammatory indications |
JP2004532871A (ja) * | 2001-05-31 | 2004-10-28 | ファルマシア・コーポレーション | 皮膚浸透性シクロオキシゲナーゼ−2選択的阻害組成物 |
JP4283507B2 (ja) * | 2002-08-02 | 2009-06-24 | 久光製薬株式会社 | 経皮投与用貼付剤 |
-
2003
- 2003-10-10 US US10/683,943 patent/US20040126415A1/en not_active Abandoned
- 2003-11-07 AU AU2003291386A patent/AU2003291386A1/en not_active Abandoned
- 2003-11-07 WO PCT/US2003/035638 patent/WO2004047814A1/en not_active Application Discontinuation
- 2003-11-07 BR BR0316463-2A patent/BR0316463A/pt not_active IP Right Cessation
- 2003-11-07 MX MXPA05004989A patent/MXPA05004989A/es unknown
- 2003-11-07 EP EP03768780A patent/EP1572166A1/en not_active Withdrawn
- 2003-11-07 CA CA002506628A patent/CA2506628A1/en not_active Abandoned
- 2003-11-07 JP JP2004555394A patent/JP2006509759A/ja not_active Withdrawn
- 2003-11-19 PA PA20038589001A patent/PA8589001A1/es unknown
- 2003-11-20 AR ARP030104294A patent/AR042102A1/es unknown
- 2003-11-20 NL NL1024830A patent/NL1024830C2/nl not_active IP Right Cessation
- 2003-11-20 TW TW092132570A patent/TW200503787A/zh unknown
- 2003-11-20 GT GT200300249A patent/GT200300249A/es unknown
- 2003-11-21 PE PE2003001182A patent/PE20041026A1/es not_active Application Discontinuation
- 2003-11-21 UY UY28086A patent/UY28086A1/es not_active Application Discontinuation
Also Published As
Publication number | Publication date |
---|---|
MXPA05004989A (es) | 2005-08-02 |
US20040126415A1 (en) | 2004-07-01 |
EP1572166A1 (en) | 2005-09-14 |
NL1024830C2 (nl) | 2006-03-06 |
BR0316463A (pt) | 2005-10-11 |
UY28086A1 (es) | 2004-06-30 |
PA8589001A1 (es) | 2005-02-04 |
CA2506628A1 (en) | 2004-06-10 |
TW200503787A (en) | 2005-02-01 |
AR042102A1 (es) | 2005-06-08 |
NL1024830A1 (nl) | 2004-05-26 |
GT200300249A (es) | 2004-07-12 |
AU2003291386A1 (en) | 2004-06-18 |
WO2004047814A1 (en) | 2004-06-10 |
JP2006509759A (ja) | 2006-03-23 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
PE20041026A1 (es) | Composicion que comprende un inhibidor de ciclooxigenasa-2 selectivo soluble en agua | |
BR0312268A (pt) | Dispositivos transdermais para liberação de droga que têm microprotrusões revestidas | |
BRPI0417437A (pt) | dispositivo para inibição da absorção, dispositivo para remoção de agente fisiologicamente ativo e dispositivo para redução do efeito de overdose | |
MXPA04001491A (es) | Dispositivo de liberacion de farmaco erosionable mucoadhesivo para la administracion controlada de compuestos activos farmaceuticos y otros compuestos activos. | |
WO2004078122A3 (en) | Invisible patch for active agnet controlled delivery | |
BRPI0313148B8 (pt) | formulações sólidas matriciais de lamotrigina contendo revestimento externo e perfuração em tal revestimento | |
BRPI0514031A (pt) | artigos absorventes compreendendo um agente modificador de exsudado corpóreo e uma formulação de cuidado com a pele que forma filme | |
DE60213228D1 (de) | Zusammensetzungen für die freisetzung von protein auf dem pulmonalen weg | |
HUP0202311A2 (hu) | Aeroszollá alakított fertőzésgátló, gyulladásgátló és vértolulást gátló szerek az orrmelléküreg-gyulladás kezelésében | |
ES2095174T3 (es) | Composicion cosmetica o dermatologica estabilizada que contiene varios precursores de un mismo agente activo. | |
DK1333880T3 (da) | Indretninger med coatede mikrofremspring til medikamentafgivelse gennem huden | |
BRPI0415986A (pt) | método e aparelho para reduzir a incidência do uso de tabaco | |
AR042104A1 (es) | Lamina revestida de adhesivo para administracion dermica de un inhibidor selectivo de ciclooxigenasa -2 | |
ATE319488T1 (de) | Bioaktive-wirkstofffreisetzende beschichtung mit aromatischen poly(meth)acrylaten | |
BR0008254A (pt) | Combinações para o tratamento de doenças que envolvam angiogênese | |
WO2011029948A3 (de) | Transdermales therapeutisches system zur verabreichung von fentanyl oder einem analogstoff davon | |
MX2009008993A (es) | Dispositivo para la administracion percutanea de bisoprolol. | |
MXPA05010384A (es) | Composiciones adherentes para el cuidado de la piel y articulos que tienen las composiciones adherentes para el cuidado de la piel colocadas encima. | |
DK1046395T3 (da) | Plaster indeholdende heparin og diclofenac til topisk anvendelse | |
BRPI0406858A (pt) | Liberação controlada de agentes altamente solúveis | |
ES2188995T3 (es) | Uso de un inhibidor de la h+, k+-atpasa en el tratamiento de los polipos nasales. | |
BR0316436A (pt) | Emplastro inibidor seletivo de ciclooxigenase-2 | |
AR055453A1 (es) | Uso de la idebenona en una composicion destinada a ser aplicada sobre la piel y composicion que la comprende | |
AR046146A1 (es) | Formulaciones farmaceuticas transdermicas para pulverizacion que comprenden un agente activo, un copolimero de vp/va y un vehiculo no acuoso | |
WO2002017928A3 (de) | Transdermales therapeutisches system zur abgabe von exemestan |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FC | Refusal |